Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
Socrates phase II study result...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
Bibliografiska uppgifter
Huvudupphovsmän:
Glynne-Jones, R
,
Sebag-Montefiore, D
,
Samuel, L
,
Falk, S
,
Maughan, T
,
McDonald, A
Materialtyp:
Conference item
Publicerad:
2005
Beståndsuppgifter
Beskrivning
Liknande verk
Katalogiseringsuppgifter
Liknande verk
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
av: Glynne-Jones, R, et al.
Publicerad: (2004)
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
av: Sebag-Montefiore, D, et al.
Publicerad: (2005)
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
av: Glynne-Jones, R, et al.
Publicerad: (2007)
Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study
av: Evans, T, et al.
Publicerad: (2006)
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
av: Anchuan Li, et al.
Publicerad: (2022-07-01)